Yao D, Jiang D, Huang Z, Lu J, Tao Q, Yu Z, Meng X
Research Center of Clinical Molecular Biology, Affiliated Hospital, Nantong Medical College, Jiangsu, China.
Cancer. 2000 Feb 15;88(4):761-9.
Hepatoma specific gamma-glutamyl transferase (HS-GGT) bands were expressed in the development of hepatocellular carcinoma (HCC) and were associated with a high incidence of HCC diagnosis. The objectives of this study were to determine the levels of HS-GGT quantitatively in the sera of patients with different liver diseases. The methylational status of GGT gene CCGG sites was analyzed in hepatoma tissues.
The HS-GGT concentrations were quantitatively analyzed in the sera of 156 HCC patients and others with liver diseases or extrahepatic tumors. In 20 hepatoma tissues, the GGT enzyme proteins were purified, the activities of GGTs of different molecular form were examined, total RNAs were extracted and amplified by using a nested polymerase chain reaction (PCR) assay, and the methylational status of CCGG site (M3) in the 5'-noncoding region of GGT genes was investigated with the restriction enzyme Hpa II.
Total GGT activities in patients with liver diseases and extrahepatic tumors were abnormally increased. The levels of serum HS-GGT were significantly elevated (P < 0.001) in the HCC group; the incidence of HS-GGT over 5.5 IU/L was 86% in HCC patients and less than 3% in patients with other diseases. From liver cancer to distal noncancerous tissues, an increasing tendency (P < 0.05) of total RNA concentrations was found; the frequencies of amplified fragment and hypomethylated M3 site of GGT genes were 100% and 75% in HCC, 85% and 55% in paracancerous tissues, and 75% and 50% in noncancerous tissues, respectively. An inverse correlation was found between methylational degrees of GGT genes and expression levels of GGT.
The abnormal alteration of serum HS-GGT level is a sensitive tumor marker for HCC diagnosis or differentiation, and the overexpression of GGT in HCC may be related to the hypomethylational status of CCGG sites of GGT genes.
肝癌特异性γ-谷氨酰转移酶(HS-GGT)条带在肝细胞癌(HCC)发生过程中表达,且与HCC诊断的高发生率相关。本研究的目的是定量测定不同肝病患者血清中HS-GGT的水平。分析肝癌组织中GGT基因CCGG位点的甲基化状态。
对156例HCC患者及其他患有肝病或肝外肿瘤患者的血清进行HS-GGT浓度定量分析。在20例肝癌组织中,纯化GGT酶蛋白,检测不同分子形式GGT的活性,提取总RNA并通过巢式聚合酶链反应(PCR)进行扩增,用限制性内切酶Hpa II研究GGT基因5'-非编码区CCGG位点(M3)的甲基化状态。
肝病患者和肝外肿瘤患者的总GGT活性异常升高。HCC组血清HS-GGT水平显著升高(P<0.001);HS-GGT超过5.5 IU/L的发生率在HCC患者中为86%,在其他疾病患者中低于3%。从肝癌组织到远端非癌组织,总RNA浓度呈上升趋势(P<0.05);GGT基因扩增片段和M3位点低甲基化的频率在肝癌组织中分别为100%和75%,癌旁组织中为85%和55%,非癌组织中为75%和50%。GGT基因甲基化程度与GGT表达水平呈负相关。
血清HS-GGT水平的异常改变是HCC诊断或鉴别诊断的敏感肿瘤标志物,HCC中GGT的过表达可能与GGT基因CCGG位点的低甲基化状态有关。